ATN/AIR-P Works in Progress Webinar: Genetic Testing
3:00pmET
Dr. Gail E Herman, MD/PhD, will discuss the role of genetics in the etiology of autism spectrum disorders (ASDs), as well as current recommendations for genetic testing in individuals with an ASD diagnosis. She will also briefly discuss exciting new research findings concerning genes involved in ASDs and new modes of genetic testing (whole exome and genome sequencing) that are rapidly entering the clinical arena. Dr. Herman is a board-certified clinical and biochemical geneticist and genetics specialist for the ATN at Nationwide Children's Hospital. She is also President-elect of the American College of Medical Genetics and Genomics.
The educational objectives for this webinar are as follows:
- Assess the evidence implicating genetics in the etiology of autism spectrum disorders
- Identify and order appropriate first tier genetic testing in individuals with an ASD and know when to refer for a genetic evaluation
- Identify the new genetic testing modalities of whole exome and whole genome sequencing and their potential role in ASD genetic diagnosis
Earn 1 CME
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Nationwide Children's Hospital and Autism Speaks. The Nationwide Children's Hospital is accredited by the ACCME to provide continuing medical education for physicians.
The Nationwide Children's Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Others in control of content include: Daniel Coury, MD; James Perrin, MD; Brian Winklosky, MA; Clara Lajonchere, PhD; Kirsten Klatka, MSW; Curtis Thompson, M.Ed.; Karen Heiser; W. Dawdy, MD; Becky Williams, M.Ed; Alixandra Nozzolillo, MS. They have no relationships with commercial interests. No other individuals in position to control content have any relevant relationships with commercial interests.
